Speciality: Oncology
Description:
A warm welcome to all the medical professionals joining this insightful session on the role of pazopanib in managing advanced renal cell carcinoma (RCC).
Kidney cancer, also known as renal cancer, is one of the more common cancers affecting both men and women, and its global burden continues to rise steadily. Advanced RCC, which corresponds to stage 4 kidney cancer, poses significant challenges in treatment and is often not curable.
Typically, healthcare providers focus on slowing disease progression, alleviating symptoms, and enhancing the quality of life for patients. However, continuous advancements in oncology research have led to the development and FDA approval of promising new treatment options.
Pazopanib is an anti-cancer agent that works by inhibiting tumor cell growth through multiple mechanisms. It targets key proteins, primarily tyrosine kinases, located on the surface of cancer cells. Many of these proteins play a critical role in angiogenesis, the process of forming new blood vessels that feed tumor growth.
We encourage you to stay engaged in this webinar, absorb the latest clinical insights shared by experts, and follow HiDoc for more such valuable sessions focused on advancing medical knowledge and practice.
See More Webinars @ Hidoc Webinars
1.
Survival is extended by a new treatment option for metastatic colorectal cancer.
2.
Six breast texture patterns linked to higher risk of invasive cancer
3.
New policy review highlights the importance of health-related quality of life in advanced cancer
4.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
5.
Climate change is expected to increase the number of suicide deaths
1.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
2.
Exploring Innovative Approaches to Esophageal Cancer Treatment
3.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
4.
Exploring the Latest Advances in PTLD Cancer Treatment
5.
The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation